$342.39M
Revenue
$3.58M
Net Income
79.25%
Gross Margin
-0.25%
Op. Margin
$133.14M
Free Cash Flow
| Breakdown | Q4 2025 (Dec 31, 2025) |
Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
|---|---|---|---|---|---|---|---|
| Total Revenue | $88.53M | $83.26M | $86.03M | $84.57M | $98.38M | $98.62M | $87.93M |
| Revenue Growth % (YoY) | -10.0% | -15.6% | -2.2% | nan% | nan% | nan% | nan% |
| Cost of Revenue | $18.90M | $17.14M | $17.93M | $17.09M | $15.15M | $12.17M | $12.28M |
| Gross Profit | $69.63M | $66.12M | $68.10M | $67.48M | $83.23M | $86.45M | $75.64M |
| Gross Margin % | 78.7% | 79.4% | 79.2% | 79.8% | 84.6% | 87.7% | 86.0% |
| Operating Expenses | $71.27M | $63.75M | $66.87M | $70.28M | $70.26M | $65.74M | $97.30M |
| Research & Development | $14.25M | $14.02M | $14.74M | $18.07M | $15.82M | $16.29M | $17.53M |
| Operating Income | $-1.64M | $2.37M | $1.24M | $-2.80M | $12.97M | $20.71M | $-21.66M |
| Operating Margin % | -1.9% | 2.8% | 1.4% | -3.3% | 13.2% | 21.0% | -24.6% |
| Interest Expense | $329.00K | $171.00K | $96.00K | $21.00K | $1.07M | $2.53M | $2.50M |
| Other Income/Expense | $-64.00K | $376.00K | $-6.00K | $-399.00K | $-25.00K | $-16.00K | $-1.41M |
| Income Before Tax | $244.00K | $5.25M | $3.87M | $483.00K | $17.00M | $25.13M | $-30.03M |
| Income Tax Expense | $1.25M | $3.72M | $1.38M | $-72.00K | $-59.17M | $7.89M | $3.94M |
| Net Income | $-1.00M | $1.53M | $2.49M | $555.00K | $76.17M | $17.24M | $-33.97M |
| Net Margin % | -1.1% | 1.8% | 2.9% | 0.7% | 77.4% | 17.5% | -38.6% |
| Basic EPS | -0.03 | 0.05 | 0.09 | 0.02 | 3.19 | 0.56 | -1.32 |
| Diluted EPS | -0.03 | 0.05 | 0.08 | 0.02 | 2.90 | 0.51 | -1.32 |
| Basic Shares Outstanding | - | 28.0M | 28.5M | 30.8M | 2.2M | 30.7M | 25.7M |
| Diluted Shares Outstanding | - | 29.4M | 30.4M | 33.2M | 5.0M | 33.6M | 25.7M |
| Breakdown | Q4 2025 (Dec 31, 2025) |
Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $186.61M | $223.30M | $250.55M | $297.12M | $349.28M | $341.27M | $317.86M |
| Accounts Receivable | $208.71M | $212.82M | $208.98M | $206.16M | $220.88M | $227.79M | $209.02M |
| Other Current Assets | $12.60M | $19.28M | $23.06M | $24.29M | $11.17M | $6.99M | $7.35M |
| Total Current Assets | $407.93M | $455.46M | $482.65M | $527.99M | $581.74M | $576.06M | $534.23M |
| Property Plant & Equipment | $23.43M | $19.58M | $9.04M | $4.44M | $1.95M | $2.06M | $2.27M |
| Other Non-current Assets | $1.08M | $962.00K | $738.00K | $792.00K | $794.00K | $183.00K | $652.00K |
| Total Assets | $525.91M | $569.43M | $600.78M | $639.26M | $678.43M | $598.27M | $556.05M |
| Accounts Payable | $10.84M | $15.31M | $10.60M | $11.30M | $7.16M | $8.25M | $5.24M |
| Accrued Liabilities | $19.61M | $16.72M | $17.83M | $15.13M | $17.96M | $18.50M | $16.92M |
| Other Current Liabilities | $1.25M | $1.54M | $4.82M | $5.48M | $6.09M | $3.60M | $3.60M |
| Total Current Liabilities | $207.76M | $206.53M | $204.03M | $196.50M | $204.16M | $211.47M | $190.17M |
| Long-term Debt | - | - | - | - | - | - | - |
| Other Non-current Liabilities | - | - | - | - | $16.98M | $8.84M | $6.18M |
| Total Liabilities | $238.26M | $239.82M | $246.65M | $237.99M | $221.15M | $220.31M | $196.35M |
| Common Stock | - | - | - | - | - | - | - |
| Retained Earnings | $-136.87M | $-135.87M | $-137.40M | $-139.89M | $-140.45M | $-216.62M | $-233.86M |
| Total Stockholders Equity | $287.65M | $329.61M | $354.13M | $401.28M | $457.28M | $377.96M | $359.70M |
| Total Liabilities & Equity | $525.91M | $569.43M | $600.78M | $639.26M | $678.43M | $598.27M | $556.05M |
| Breakdown | Q4 2025 (Dec 31, 2025) |
Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
|---|---|---|---|---|---|---|---|
| Net Income | $-1.00M | $1.53M | $3.04M | $555.00K | $76.17M | $17.24M | $-24.67M |
| Depreciation & Amortization | $2.47M | $5.85M | $4.61M | $2.17M | $1.92M | $6.16M | $4.02M |
| Stock-based Compensation | $10.68M | $33.46M | $23.05M | $11.59M | $10.67M | $36.25M | $24.80M |
| Change in Receivables | $-4.09M | $-6.14M | $-10.46M | $-14.31M | $-6.96M | $2.56M | $-16.74M |
| Change in Payables | $-1.11M | $1.47M | $1.13M | $273.00K | $-1.10M | $188.00K | $-2.92M |
| Operating Cash Flow | $27.80M | $67.47M | $45.72M | $19.86M | $21.99M | $93.93M | $54.39M |
| Capital Expenditure | $7.53M | $12.77M | $5.52M | $1.89M | $216.00K | $655.00K | $353.00K |
| Investing Cash Flow | $-11.18M | $-23.13M | $-11.97M | $-4.97M | $-2.54M | $-7.66M | $-4.79M |
| Stock Repurchased | $54.79M | $178.18M | $140.18M | $69.78M | $15.71M | $15.61M | - |
| Financing Cash Flow | $-53.37M | $-170.68M | $-132.83M | $-67.05M | $-11.03M | $192.41M | $205.67M |
| Net Change in Cash | $-36.74M | $-126.34M | $-99.08M | $-52.16M | $8.42M | $278.68M | $255.27M |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $83.26M | - | $253.86M | - |
| Cost of Revenue | $17.14M | - | $52.16M | - |
| Gross Profit | $66.12M | - | $201.70M | - |
| Operating Expenses | $63.75M | - | $200.90M | - |
| Research & Development | $14.02M | - | $46.84M | - |
| Operating Income | $2.37M | - | $801.00K | - |
| Interest Expense | - | - | $171.00K | - |
| Other Income/Expense | $376.00K | - | $-29.00K | - |
| Income Before Tax | $5.25M | - | $9.60M | - |
| Income Tax Expense | $3.72M | - | $5.03M | - |
| Net Income | $1.53M | $-33.97M | $4.58M | - |
| Basic EPS | 0.05 | - | 0.16 | - |
| Diluted EPS | 0.05 | - | 0.15 | - |
| Basic Shares Outstanding | $28.00M | - | $29.07M | - |
| Diluted Shares Outstanding | $29.38M | - | $31.00M | - |
Condensed Consolidated Balance Sheets
| Description | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
| Cash & Cash Equivalents | $223.30M | $349.28M |
| Accounts Receivable | $212.82M | $220.88M |
| Other Current Assets | $19.28M | $11.17M |
| Total Current Assets | $455.46M | $581.74M |
| Property Plant & Equipment | $19.58M | $1.95M |
| Other Non-current Assets | $962.00K | $794.00K |
| Total Assets | $569.43M | $678.43M |
| Accounts Payable | $15.31M | $7.16M |
| Accrued Liabilities | $16.72M | $17.96M |
| Other Current Liabilities | $1.54M | $6.09M |
| Total Current Liabilities | $206.53M | $204.16M |
| Total Liabilities | $239.82M | $221.15M |
| Retained Earnings | $-135.87M | $-140.45M |
| Total Stockholders Equity | $329.61M | $457.28M |
| Total Liabilities & Equity | $569.43M | $678.43M |
Condensed Consolidated Statements of Cash Flows
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $1.53M | $-33.97M | $4.58M | - |
| Depreciation & Amortization | - | - | $5.85M | - |
| Stock-based Compensation | - | - | $33.46M | - |
| Change in Receivables | - | - | $-6.14M | - |
| Change in Payables | - | - | $1.47M | - |
| Operating Cash Flow | - | - | $67.47M | - |
| Capital Expenditure | - | - | $12.77M | - |
| Investing Cash Flow | - | - | $-23.13M | - |
| Stock Repurchased | - | - | $178.18M | - |
| Financing Cash Flow | - | - | $-170.68M | - |
| Net Change in Cash | - | - | $-126.34M | - |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.
Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.